Gain Therapeutics, Inc. (GANX) quarterly cash flow statement — complete operating, investing & financing history
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 | Q3'21 | Q2'21 |
|---|
| Cash from Operations | -4.73M | -4.62M | -4.93M | -5.1M | -3.82M | -3.45M | -6.08M | -5.76M | -3.59M | -5.66M | -3.97M | -5.02M | -4.22M | -3.9M | -3.29M | -5.05M | -2.45M | -4.15M | -2.19M | -3.22M |
| Operating CF Margin % | - | - | - | - | - | - | - | - | - | - | - | - | -7643.01% | - | - | -5311.2% | -5437.92% | -9596.29% | -8017.33% | -3607.66% |
| Operating CF Growth % | -23.71% | -33.69% | 18.92% | 11.42% | -6.55% | 38.97% | -53.18% | -14.64% | 14.96% | -44.97% | -20.6% | 0.59% | -72.32% | 5.83% | -50.03% | -57.01% | 12.9% | -216.95% | -190.37% | - |
| Net Income | -5.61M | -4.54M | -5.28M | -5.81M | -4.53M | -3.77M | -4.49M | -8.14M | -4.01M | -4.72M | -4.72M | -7.69M | -5.14M | -4.67M | -4.56M | -5.09M | -3.27M | -3.22M | -4.66M | -3.56M |
| Depreciation & Amortization | 21.3K | 28.24K | 22.82K | 22.33K | 20.66K | 21.31K | 21.64K | 20.59K | 20.53K | 23.59K | 20.51K | 20.24K | 19.24K | 18.11K | 17.83K | 20.02K | 8.21K | 5.79K | 4.13K | 2.16K |
| Stock-Based Compensation | 0 | 401.67K | 460K | 522.02K | 419.5K | 359.33K | 357.5K | 1.48M | 190.42K | 555.06K | 907.33K | 1.23M | 565.43K | 558.69K | 355.65K | 305.55K | 306.55K | -575.41K | 250.82K | 191.56K |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Cash Items | 633.97K | 11.19K | 10.86K | 673.29K | 109.59K | 553.98K | -44.18K | -166.13K | -200.15K | -135.7K | -171.11K | 45.85K | -122.24K | -140.97K | -35.84K | -76.35K | 46.3K | -802.63K | 496.76K | 314.94K |
| Working Capital Changes | 225.93K | -522.01K | -135.75K | -507.53K | 158.78K | -621.03K | -1.93M | 1.05M | 416.81K | -1.38M | -5.18K | 1.37M | 457.47K | 334.02K | 931.5K | -214.86K | 464.2K | 445.81K | 1.72M | -169.03K |
| Change in Receivables | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 24.43K | 328.45K | -344.62K |
| Change in Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Payables | 531.77K | -785.26K | -949.14K | 151.65K | 1.11M | -58.07K | -1.85M | 1.48M | 703.59K | -976.79K | -46.1K | -677.85K | 1.06M | -466.85K | 300.59K | -310.97K | 1.54M | 0 | 1.16M | 8.13K |
| Cash from Investing | 0 | 0 | 0 | 0 | 0 | -43.45K | -1 | 2M | 3.02M | 3.14M | 1.93M | 3.05M | 2.11M | 133.83K | -11.41K | -14.89M | -7.83K | -11.1K | -32.12K | -22.5K |
| Capital Expenditures | 0 | 0 | 0 | 0 | 0 | -945 | -1 | -21.55K | 0 | -19 | -650 | -3.64K | -11.04K | -9.4K | -57.18K | -44.55K | -7.83K | -11.1K | -32.12K | -22.5K |
| CapEx % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | 20.02% | - | - | 46.85% | 17.39% | 25.69% | 117.47% | 25.24% |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1M | -1M | 0 | 0 | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -1M | 1M | 0 | 0 | 0 | 0 | 0 |
| Cash from Financing | 404.32K | 16.55M | 7.03M | 2.47M | 2.4M | 2.31M | 808.68K | 10.04M | -145.8K | 9.56M | 134.47K | 2.2M | 748.91K | -21.58K | -20.58K | 1.36K | -37.97K | -9.73K | 0 | -213.79K |
| Debt Issued (Net) | -25.52K | -25.02K | -25K | -24.24K | -22.24K | -22.78K | -23.12K | -22.11K | -22.87K | -22.58K | -22.63K | -22.25K | -21.61K | -21.58K | -20.58K | 1.36K | -37.97K | 0 | 0 | 0 |
| Equity Issued (Net) | 429.85K | 16.58M | 7.41M | 2.49M | 2.42M | 2.34M | 831.79K | 10.04M | 157.94K | 9.58M | 157.1K | 2.22M | 770.52K | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | 0 | 0 | -353.73K | 0 | 0 | -1 | 1 | 13.57K | -280.87K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -9.73K | 0 | -213.79K |
| Net Change in Cash | -4.3M | 12.03M | 2.11M | -2.37M | -1.31M | -1.67M | -4.88M | 6.3M | -1.15M | 7.53M | -2.05M | 332.42K | -1.32M | -3.57M | -3.43M | -20.03M | -2.54M | -4.1M | -2.19M | -3.43M |
| Free Cash Flow | -4.73M | -4.62M | -4.93M | -5.1M | -3.82M | -3.46M | -6.08M | -5.78M | -3.59M | -5.66M | -3.97M | -5.03M | -4.23M | -3.91M | -3.35M | -5.1M | -2.46M | -4.16M | -2.22M | -3.24M |
| FCF Margin % | - | - | - | - | - | - | - | - | - | - | - | - | -7663.03% | - | - | -5358.05% | -5455.31% | -9621.98% | -8134.8% | -3632.9% |
| FCF Growth % | -23.71% | -33.65% | 18.92% | 11.75% | -6.55% | 38.95% | -53.15% | -14.98% | 15.18% | -44.62% | -18.56% | 1.39% | -72.22% | 5.86% | -50.43% | -57.29% | 13.5% | -214.3% | -194.07% | - |
| FCF per Share | -0.11 | -0.14 | -0.14 | -0.17 | -0.13 | -0.13 | -0.23 | -0.30 | -0.20 | -0.35 | -0.31 | -0.41 | -0.35 | -0.33 | -0.28 | -0.43 | -0.21 | -0.41 | -0.19 | -0.27 |
| FCF Conversion (FCF/Net Income) | 0.84x | 1.02x | 0.93x | 0.88x | 0.84x | 0.92x | 1.35x | 0.71x | 0.89x | 1.20x | 0.84x | 0.65x | 0.82x | 0.84x | 0.72x | 0.99x | 0.75x | 1.29x | 0.47x | 0.90x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |